Published in Surgery Litigation and Law Weekly, February 5th, 2010
As part of a 2007 suit, Johnson & Johnson alleged that Boston Scientific's PROMUS® Everolimus-Eluting Coronary Stent System infringed these four patents, known as the Wright/Falotico patents. The patents relate to coatings (drug and polymer) for drug-eluting stents.
The Court ruled today that a trial on the four patents, which was scheduled to begin February 9, will not proceed.
"We are pleased with the Court's finding that all four Johnson...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly